Tsuneyo Mimori

Q: What Schools Are Affiliated With Tsuneyo Mimori

Tsuneyo Mimori is affiliated with the following schools: Hokkaido University, Yale University, Tohoku University, University of Tokyo, Augusta University, Osaka University, Kyoto University

Tsuneyo Mimori's AcademicInfluence.com Rankings

Tsuneyo Mimori

Computer Science

#7012

World Rank

#7386

Historical Rank

Computational Linguistics

#1323

World Rank

#1338

Historical Rank

Machine Learning

#2456

World Rank

#2488

Historical Rank

Artificial Intelligence

#2741

World Rank

#2784

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Tsuneyo Mimori's Degrees

PhD Computer Science University of Tokyo
Masters Computer Science Kyoto University
Bachelors Computer Science Kyoto University

Similar Degrees You Can Earn

Why Is Tsuneyo Mimori Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Tsuneyo Mimori's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genetics of rheumatoid arthritis contributes to biology and drug discovery (2013) (1877)
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 (2012) (1021)
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 (2012) (914)
International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease (2015) (763)
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details (2011) (605)
Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. (2005) (584)
Mechanism of interaction between Ku protein and DNA. (1986) (475)
Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. (1981) (404)
The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies. (1984) (305)
Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. (1986) (304)
Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population (2012) (299)
Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome (2011) (283)
Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study (2010) (276)
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. (2010) (273)
A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility (2010) (254)
Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system (2006) (251)
Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014–2015 (2015) (248)
The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. (1983) (218)
Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. (2010) (208)
Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective (2019) (184)
Leptin inhibits stress‐induced apoptosis of T lymphocytes (2002) (172)
High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis (2003) (172)
Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies (2006) (171)
Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. (2009) (169)
Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. (1996) (169)
DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double-stranded DNA. (1994) (169)
Complement drives Th17 cell differentiation and triggers autoimmune arthritis (2010) (167)
Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. (2001) (167)
Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. (1999) (166)
Current approach to the diagnosis of IgG4-related disease – Combination of comprehensive diagnostic and organ-specific criteria (2017) (165)
Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis (2005) (161)
Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance (2007) (157)
Comprehensive microRNA Analysis Identifies miR-24 and miR-125a-5p as Plasma Biomarkers for Rheumatoid Arthritis (2013) (155)
Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. (1993) (153)
Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis (2013) (152)
Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome. (1990) (134)
Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis (2020) (128)
Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment (2012) (127)
Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. (2013) (125)
Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with scleroderma-polymyositis overlap syndrome. (1984) (124)
Laminin 511 is a target antigen in autoimmune pancreatitis (2018) (120)
Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis. (2000) (119)
Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. (1992) (119)
Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts. (1985) (114)
A Genome-Wide Association Study Identified AFF1 as a Susceptibility Locus for Systemic Lupus Eyrthematosus in Japanese (2012) (112)
International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results (2016) (112)
HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. (2011) (110)
Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease. (2016) (106)
Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. (2011) (102)
Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. (2007) (98)
A Clinical, Pathological, and Genetic Characterization of Methotrexate-associated Lymphoproliferative Disorders (2014) (93)
Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies (2016) (93)
The Multicenter Study of a New Assay for Simultaneous Detection of Multiple Anti-Aminoacyl-tRNA Synthetases in Myositis and Interstitial Pneumonia (2014) (92)
Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. (2004) (91)
Ku polypeptides synthesized in vitro assemble into complexes which recognize ends of double-stranded DNA. (1992) (91)
The human AIRE gene at chromosome 21q22 is a genetic determinant for the predisposition to rheumatoid arthritis in Japanese population. (2011) (90)
Brief Report: Takayasu Arteritis and Ulcerative Colitis: High Rate of Co‐Occurrence and Genetic Overlap (2015) (88)
Recent advances in Takayasu arteritis (2014) (87)
The prognostic value of HRCT in myositis-associated interstitial lung disease. (2013) (87)
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases (2021) (87)
Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis (2018) (83)
Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis (2010) (80)
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease (2014) (79)
The Interaction between Ku Antigen and REF1 Protein Mediates Negative Gene Regulation by Extracellular Calcium (*) (1996) (78)
T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. (2000) (78)
Anti-TIF1-&ggr; antibody and cancer-associated myositis: A clinicohistopathologic study (2016) (76)
Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease (2016) (76)
Clinical significance of anti-CCP antibodies in rheumatoid arthritis. (2005) (75)
Methotrexate treatment in patients with adult onset Still’s disease—retrospective study of 13 Japanese cases (1997) (74)
Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis (2013) (74)
Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. (1995) (74)
DIP2 disco‐interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin‐related protein/follistatin‐like 1 – analysis of their binding with TGF‐β superfamily proteins (2010) (72)
Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. (2013) (72)
Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis (2016) (71)
Prognostic Significance of Anti-Aminoacyl-tRNA Synthetase Antibodies in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease: A Retrospective Case Control Study (2015) (71)
Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015 (2016) (71)
Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis. (1997) (69)
Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus. (2002) (68)
Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature (2010) (68)
Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis (2017) (68)
Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis. (2016) (67)
Effects of Smoking and Shared Epitope on the Production of Anti–Citrullinated Peptide Antibody in a Japanese Adult Population (2014) (66)
Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease. (2010) (66)
Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis (2010) (66)
Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with phosphatidylinositol 3‐kinase and phospholipase C‐γ following CD2 stimulation (2002) (65)
Contribution of a Non-classical HLA Gene, HLA-DOA, to the Risk of Rheumatoid Arthritis. (2016) (63)
Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application (2016) (62)
The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes. (1988) (61)
Hypoxia‐Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis (2017) (60)
Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies (2019) (59)
Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle. (1987) (59)
Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells. (2008) (58)
Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies. (2005) (58)
Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study (2005) (56)
Membrane‐bound form of fractalkine induces IFN‐γ production by NK cells (2003) (56)
Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma (2015) (55)
PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population. (2013) (55)
Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis. (1999) (55)
Three Groups in the 28 Joints for Rheumatoid Arthritis Synovitis – Analysis Using More than 17,000 Assessments in the KURAMA Database (2013) (55)
Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial (2013) (55)
Functional Variants in NFKBIE and RTKN2 Involved in Activation of the NF-κB Pathway Are Associated with Rheumatoid Arthritis in Japanese (2012) (53)
[Autoantibodies in myositis]. (2015) (53)
Periodontitis and Porphyromonas gingivalis in Preclinical Stage of Arthritis Patients (2015) (51)
Potential preventive effects of follistatin-related protein/TSC-36 on joint destruction and antagonistic modulation of its autoantibodies in rheumatoid arthritis. (2003) (51)
Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment. (2020) (50)
GM-CSF but Not IL-17 Is Critical for the Development of Severe Interstitial Lung Disease in SKG Mice (2014) (50)
Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay. (2009) (50)
Aberrant splicing of the milk fat globule‐EGF factor 8 (MFG‐E8) gene in human systemic lupus erythematosus (2010) (49)
Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance (2012) (49)
Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: An open-label extension of a randomized, double-blind, placebo-controlled trial (2014) (49)
Discordance and accordance between patient’s and physician’s assessments in rheumatoid arthritis (2014) (49)
Autoantigenic epitopes on DNA topoisomerase I. Clinical and immunogenetic associations in systemic sclerosis. (1993) (48)
TIP49, homologous to the bacterial DNA helicase RuvB, acts as an autoantigen in human. (1998) (48)
Re‐expression of functional P‐selectin molecules on the endothelial cell surface by repeated stimulation with thrombin (1997) (48)
Deficient Leptin Signaling Ameliorates Systemic Lupus Erythematosus Lesions in MRL/Mp-Faslpr Mice (2014) (48)
Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. (2004) (48)
Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan (2014) (47)
Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study (2016) (47)
Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with i.v. cyclophosphamide therapy. (1999) (47)
Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus. (1987) (46)
Follistatin‐related protein/follistatin‐like 1 evokes an innate immune response via CD14 and toll‐like receptor 4 (2012) (46)
Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis (2018) (45)
Scleroderma‐Polymyositis Overlap Syndrome (1987) (45)
Autoantibodies to ribonucleoproteins. (1985) (45)
Characterization and evolution of a gene encoding a Trimeresurus flavoviridis serum protein that inhibits basic phospholipase A2 isozymes in the snake's venom. (1997) (45)
Anti-MDA 5 and anti-TIF 1-c antibodies have clinical significance for patients with dermatomyositis (2010) (44)
Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. (2005) (42)
A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects (2011) (42)
Molecular cloning of cDNA encoding Sm autoantigen: derivation of a cDNA for a B polypeptide of the U series of small nuclear ribonucleoprotein particles. (1989) (42)
Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease (2017) (41)
A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept (2011) (41)
Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. (2013) (40)
Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists (2018) (39)
Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis (2018) (39)
Clinical practice guideline for Sjögren’s syndrome 2017 (2018) (37)
Subcellular localization and protein-protein interaction regions of Ku proteins. (1998) (37)
Increase of Hemoglobin Levels by Anti-IL-6 Receptor Antibody (Tocilizumab) in Rheumatoid Arthritis (2014) (37)
GM-CSF as a therapeutic target in autoimmune diseases (2016) (37)
A case of polymyositis associated with hepatitis B infection. (2000) (37)
Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases. (2017) (36)
Membrane-bound form of fractalkine induces IFN-gamma production by NK cells. (2003) (36)
Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial (2007) (36)
The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies. (2017) (36)
Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's syndrome with other sets of criteria in Japanese patients (2017) (36)
Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis. (2012) (36)
Low Prevalence of Anti-DFS70/LEDGF Antibodies in Patients with Dermatomyositis and Other Systemic Autoimmune Rheumatic Diseases (2013) (36)
Autoimmune autonomic ganglionopathy with Sjögren's syndrome: Significance of ganglionic acetylcholine receptor antibody and therapeutic approach (2009) (35)
Autoantibodies to DNA-dependent protein kinase. Probes for the catalytic subunit. (1996) (34)
ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese (2012) (34)
Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells (2012) (34)
Detection of autoantibodies to nucleolar transcription factor NOR 90/hUBF in sera of patients with rheumatic diseases, by recombinant autoantigen-based assays. (1996) (34)
Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study (2018) (33)
Elderly onset of early rheumatoid arthritis is a risk factor for bone erosions, refractory to treatment: KURAMA cohort (2018) (33)
Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy (2015) (33)
Sp1 Family Proteins Recognize the U5 Repressive Element of the Long Terminal Repeat of Human T Cell Leukemia Virus Type I through Binding to the CACCC Core Motif* (1996) (33)
Significant association of periodontal disease with anti-citrullinated peptide antibody in a Japanese healthy population - The Nagahama study. (2015) (33)
Leukoencephalopathy with cognitive impairment following tocilizumab for the treatment of rheumatoid arthritis (RA). (2009) (32)
Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease (2017) (32)
A twin study of rheumatoid arthritis in the Japanese population (2016) (31)
Lack of association between tyrosine kinase 2 (TYK2) gene polymorphisms and susceptibility to SLE in a Japanese population (2009) (31)
Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease (2015) (30)
Clinical significance of antibodies to native or denatured 60-kd or 52-kd Ro/SS-A proteins in Sjögren's syndrome. (1994) (30)
Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study (2011) (30)
How to diagnose IgG4-related disease (2017) (30)
Autoantibodies from primary biliary cirrhosis patients with anti‐p95c antibodies bind to recombinant p97/VCP and inhibit in vitro nuclear envelope assembly (2004) (29)
Validation of different sets of criteria for the diagnosis of Sjögren’s syndrome in Japanese patients (2013) (29)
Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid Arthritis (2015) (29)
Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor (2019) (29)
Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan (2017) (29)
Myelin Basic Protein as a Novel Genetic Risk Factor in Rheumatoid Arthritis—A Genome-Wide Study Combined with Immunological Analyses (2011) (28)
Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study (2019) (27)
Anti-TIF1-γ antibody and cancer-associated myositis (2016) (27)
Structures targeted by the immune system in myositis. (1996) (27)
Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup. (2003) (27)
Chromosomal localization of the mouse and rat DNA double-strand break repair genes Ku p70 and Ku p80/XRCC5 and their mRNA expression in various mouse tissues. (1996) (26)
Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies (2017) (26)
Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis (2019) (26)
Incidence of pulmonary hypertension and its clinical relevance in patients with interstitial pneumonias: comparison between idiopathic and collagen vascular disease associated interstitial pneumonias. (2007) (26)
Spectrum and clinical significance of autoantibodies against transfer RNA. (1998) (26)
Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study (2017) (26)
Autoantibodies in connective tissue diseases: clinical significance and analysis of target autoantigens. (1999) (26)
IgG4-related disease in the Japanese population: a genome-wide association study (2019) (25)
A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production (2017) (25)
[Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis]. (1997) (25)
Takayasu's aortitis with dissection in systemic lupus erythematosus. (1999) (25)
Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. (2016) (25)
Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study (2018) (25)
Total lesion glycolysis as an IgG4-related disease activity marker (2015) (25)
Anti‐p97/VCP Antibodies: An Autoantibody Marker for a Subset of Primary Biliary Cirrhosis Patients with Milder Disease? (2006) (24)
Brief Report: Main Contribution of DRB1*04:05 Among the Shared Epitope Alleles and Involvement of DRB1 Amino Acid Position 57 in Association With Joint Destruction in Anti–Citrullinated Protein Antibody–Positive Rheumatoid Arthritis (2015) (24)
Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population (2015) (24)
Genotyping of relapsing polychondritis identified novel susceptibility HLA alleles and distinct genetic characteristics from other rheumatic diseases. (2016) (24)
Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro. (2005) (23)
Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan (2015) (23)
Clinical and pathophysiological significance of myositis-specific and myositis-associated autoantibodies (2010) (23)
[A case of adult onset Still's disease complicated with adult respiratory distress syndrome and disseminated intravascular coagulation]. (1995) (23)
PLD4 is a genetic determinant to systemic lupus erythematosus and involved in murine autoimmune phenotypes (2019) (23)
T cell receptor clonotypes in skin lesions from patients with systemic lupus erythematosus. (1998) (22)
Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis (2016) (22)
Periodic fever and erythema nodosum associated with MDS with trisomy 8: report of two cases and review of the literature (2010) (22)
Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease. (2017) (22)
Skin ulcer is a predictive and prognostic factor of acute or subacute interstitial lung disease in dermatomyositis (2013) (22)
Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study (2016) (22)
How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative (2021) (21)
Clinical effects of ghrelin on gastrointestinal involvement in patients with systemic sclerosis. (2014) (21)
Aseptic meningitis in mixed connective tissue disease: cytokine and anti-U1RNP antibodies in cerebrospinal fluids from two different cases (2008) (21)
Genome-Wide Association Study and Gene Expression Analysis Identifies CD 84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis (2013) (21)
Clinical significance of anti-Ku autoantibodies--a serologic marker of overlap syndrome? (2002) (20)
Autoantigen Ku protein is involved in DNA binding proteins which recognize the U5 repressive element of human T‐cell leukemia virus type I long terminal repeat (1994) (20)
[Anti-MDA5 (melanoma differentiation-associated gene 5) antibody and dermatomyositis with rapidly progressive interstitial pneumonia]. (2013) (20)
Severe subcutaneous generalized edema in a patient with dermatomyositis (2007) (20)
Overexpression of a Minimal Domain of Calpastatin Suppresses IL-6 Production and Th17 Development via Reduced NF-κB and Increased STAT5 Signals (2011) (20)
Visceral disseminated varicella zoster virus infection after rituximab treatment for granulomatosis with polyangiitis (2017) (20)
Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients. (2019) (20)
Hypertrophic osteoarthropathy, cutaneous vasculitis, and mixed-type cryoglobulinemia in a patient with nasopharyngeal carcinoma. (1987) (20)
Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC) (2018) (19)
Inverse Association between Air Pressure and Rheumatoid Arthritis Synovitis (2014) (19)
Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease (2018) (19)
Quantitative effect of HLA-DRB1 alleles to ACPA levels in Japanese rheumatoid arthritis: no strong genetic impact of shared epitope to ACPA levels after stratification of HLA-DRB1*09:01 (2012) (19)
DNA mismatch repair enzymes: genetic defects and autoimmunity. (2015) (19)
Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity. (1996) (19)
Antisynthetase syndrome associated with sarcoidosis. (2006) (19)
Clinical Activity After 12 Weeks of Treatment with Nonbiologics in Early Rheumatoid Arthritis May Predict Articular Destruction 2 Years Later (2010) (19)
Clinical characteristics related to methotrexate-induced pancytopenia (1997) (19)
A novel autoantibody reactive with a 48 kDa tRNA associated protein in patients with scleroderma. (1991) (19)
Cell-contact-dependent activation of CD4+ T cells by adhesion molecules on synovial fibroblasts (2017) (19)
Myositis and interstitial lung disease associated with autoantibody to a transfer RNA-related protein Wa. (2000) (18)
Recurrent annular erythema associated with anti‐SS‐B/La antibodies: analysis of the disease‐specific epitope (1992) (18)
Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance (2018) (18)
An Association Between Amino Acid Position 74 of HLA–DRB1 and Anti–Citrullinated Protein Antibody Levels in Japanese Patients With Anti–Citrullinated Protein Antibody–Positive Rheumatoid Arthritis (2015) (18)
Systemic lupus erythematosus associated with recurrent lupus enteritis and peritonitis (2004) (18)
Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody. (2017) (18)
Brief Report: Autoantibodies to DNA Mismatch Repair Enzymes in Polymyositis/Dermatomyositis and Other Autoimmune Diseases: A Possible Marker of Favorable Prognosis (2014) (18)
Long-term outcomes of refractory Takayasu arteritis patients treated with biologics including ustekinumab (2020) (17)
Association between autoantibodies to the Ku protein and DPB1*. (2005) (17)
Myeloperoxidase/HLA Class II Complexes Recognized by Autoantibodies in Microscopic Polyangiitis (2017) (17)
A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis. (2011) (17)
OP0040 Adding Tocilizumab or Switching to Tocilizumab Monotherapy in RA Patients with Inadequate Response to Methotrexate: 24-Week Results from a Randomized Controlled Study (Surprise Study) (2013) (17)
Interferon-gamma release assay for diagnosing Mycobacterium tuberculosis infections in patients with systemic lupus erythematosus (2011) (17)
Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis (2019) (17)
Enhancement of anti-DNA topoisomerase I autoantibody response after lung cancer in patients with systemic sclerosis. A report of two cases. (1996) (17)
The clinical characteristics of two anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody-positive interstitial lung disease patients with polymyositis/dermatomyositis. (2012) (16)
Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study (2018) (16)
Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets (2014) (16)
Successful treatment of a patient with refractory adult Still's disease by tacrolimus (2007) (16)
Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach. (2011) (16)
Factors affecting walking ability in female patients with rheumatoid arthritis (2018) (15)
Sweet's syndrome associated with systemic lupus erythematosus: A case report and review of the literature (2013) (15)
Prevention of fasting-mediated bone marrow atrophy by leptin administration. (2012) (15)
Association Between Antinuclear Antibodies and the HLA Class II Locus and Heterogeneous Characteristics of Staining Patterns: The Nagahama Study (2014) (15)
Living‐donor lobar lung transplantation for interstitial pneumonia associated with dermatomyositis (2010) (14)
Role for adapter proteins in costimulatory signals of CD2 and IL-2 on NK cell activation. (2002) (14)
Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus (2014) (14)
Identification of DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs) as a Novel Target of Bisphenol A (2012) (14)
Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma. (1994) (14)
Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenon. (2015) (14)
Autoantigenic epitopes of the B polypeptide of Sm small nuclear RNP particles. Identification of regions accessible only within the U1 small nuclear RNP. (1992) (14)
Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis (2018) (13)
Online First publication of Modern Rheumatology (2008) (13)
Living-donor lobar lung transplantation for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of a case (2012) (13)
Title Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns ( ICAP ) 2014-2015 (2018) (13)
The transmembrane form of TNF‐α drives autoantibody production in the absence of CD154: studies using MRL/Mp‐Faslpr mice (2002) (13)
Effect of Physical State on Pain Mediated Through Emotional Health in Rheumatoid Arthritis (2019) (13)
Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases (2017) (13)
[An adult case of dermatomyositis complicated with cecum perforation and panniculitis]. (1997) (13)
Autoantibodies against Forssman glycolipids in Graves' disease and Hashimoto's thyroiditis (1991) (13)
Two cases of late-onset drug-induced lupus erythematosus caused by ticlopidine in elderly men (2010) (13)
A case of systemic lupus erythematosus presenting with rectal ulcers as the initial clinical manifestation of disease. (2002) (13)
Effect of Impaired T Cell Receptor Signaling on the Gut Microbiota in a Mouse Model of Systemic Autoimmunity (2021) (13)
Ku antigen binds to Alu family DNA. (1998) (12)
First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort (2019) (12)
Mixed-cryoglobulinemia associated with cutaneous vasculitis and pulmonary symptoms. (1997) (12)
Serum matrix metalloproteinase levels in polymyositis/dermatomyositis patients with interstitial lung disease. (2019) (12)
Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice. (2009) (12)
Systemic lupus erythmatosus associated with autoimmune hepatitis two cases with novel autoantibodies to transfer RNA-related antigens (1997) (12)
The association between serious infection and disease outcome in patients with rheumatoid arthritis (2015) (12)
Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study (2018) (11)
Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody–positive Polymyositis/dermatomyositis–associated Interstitial Lung Disease: A Propensity Score–matched Analysis (2019) (11)
Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort (2016) (11)
The present and future perspectives of Modern Rheumatology (2006) (11)
Systemic effects of surgical intervention on disease activity, daily function, and medication in patients with rheumatoid arthritis (2016) (11)
Identification of a DRB1*0405 variant (DRB1*04052) using the PCR-RFLP method. (1996) (11)
Periarticular osteoporosis of the forearm correlated with joint destruction and functional impairment in patients with rheumatoid arthritis (2016) (11)
Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis. (2014) (11)
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation (2019) (11)
Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission (2018) (10)
Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial (2019) (10)
Phenotyping of IgG4-related diseases based on affected organ pattern: A multicenter cohort study using cluster analysis (2020) (10)
Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease (2018) (10)
Utility of osteopontin in cerebrospinal fluid as a diagnostic marker for neuropsychiatric systemic lupus erythematosus (2019) (10)
Pseudoscleroderma associated with transforming growth factor beta1-producing advanced gastric carcinoma: comment on the article by Varga. (2003) (10)
Trans-ancestry genome-wide association study identifies novel genetic mechanisms in rheumatoid arthritis (2021) (10)
Time-averaged disease activity fits better joint destruction in rheumatoid arthritis (2017) (10)
Relationship between handedness and joint involvement in rheumatoid arthritis (2016) (10)
[Anti-cyclic citrullinated peptide (CCP) antibodies]. (2010) (10)
Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis (2020) (10)
Serological and Progression Differences of Joint Destruction in the Wrist and the Feet in Rheumatoid Arthritis - A Cross-Sectional Cohort Study (2015) (10)
[Spontaneous remission of dermatomyositis which developed one month after normal delivery]. (1992) (10)
A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts. (2016) (9)
Thigh muscle MRI findings in myopathy associated with anti‐mitochondrial antibody (2020) (9)
Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease (2018) (9)
A trans-ethnic genetic study of rheumatoid arthritis identified FCGR2A as a candidate common risk factor in Japanese and European populations (2012) (9)
Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis (2019) (8)
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis (2022) (8)
Anti-EJ, anti-MDA5 double-positive chronic clinically amyopathic dermatomyositis: a case report (2018) (8)
Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5. (2020) (8)
A case of polymyositis with anti-OJ (isoleucyl-transfer RNA synthetase) antibodies. (1999) (8)
A novel splice variant of human L-selectin encodes a soluble molecule that is elevated in serum of patients with rheumatic diseases. (2015) (8)
Chronic arthritis and carpo:metacarpal ratio in Japanese patients with adult Still's disease. (1998) (8)
Intake frequency of vegetables or seafoods negatively correlates with disease activity of rheumatoid arthritis (2020) (8)
Opinions of Japanese rheumatology physicians regarding clinical practice guidelines. (2010) (8)
HLA-DRB1 Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide Antibodies (2018) (7)
Anti-nuclear antibody development is associated with poor treatment response to biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. (2019) (7)
Changing autoantibody profiles with variable clinical manifestations in a patient with relapsing systemic lupus erythematosus and polymyositis. (1995) (7)
Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan (2018) (7)
Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis (2017) (7)
Systemic lupus erythematosus associated with Down syndrome. (2000) (7)
Methotrexate‐associated EBV‐positive vasculitis in the skin: a report of two cases simulating rheumatoid vasculitis (2016) (7)
[Interstitial lung disease in patients with connective tissue diseases]. (1995) (7)
A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex (2014) (7)
Nonprecipitating IgG or IgM anti-Sm antibody: clinical significance and changes in immunoglobulin class. (1993) (7)
Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis (2018) (7)
AB0431 Post-marketing surveillance of tofacitinib in japanese patients with rheumatoid arthritis: an interim report of safety data (2017) (7)
[A case of dermatomyositis associated with different types of cancers at intervals of six years]. (2004) (7)
Novel autoantibodies directed against the common tertiary configuration of transfer RNA in a patient with interstitial lung disease. (1996) (7)
Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD (2020) (6)
SAT0257 Clinical and Radiographic Effects after 52-Week of Adding Tocilizumab or Switching to Tocilizumab in RA Patients with Inadequate Response to Methotrexate: Results from A Prospective Randomized Controlled Study (Surprise Study) (2014) (6)
Persistent anemia and hypoalbuminemia in rheumatoid arthritis patients with low serum triiodothyronine level (2020) (6)
Severe joint deformity and patient global assessment of disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients (2020) (6)
Serum IgG levels demonstrate seasonal change in connective tissue diseases: a large-scale, 4-year analysis in Japanese (2012) (6)
Characterization of autoantibodies that recognize U4/U6 small ribonucleoprotein particles in serum from a patient with primary Sjögren's syndrome. (1992) (6)
Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice (2018) (6)
Adult‐onset asthma and periocular xanthogranuloma associated with IgG4‐related disease with infiltration of regulatory T cells (2017) (6)
Juvenile polymyositis associated with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody in a 13-year-old girl (2017) (6)
AB0334 Very high titer of anti-citrullinated protein antibodies is associated with the achievement of clinical remission by abatacept in biologic-naïve patients with rheumatoid arthritis (the abroad study) (2013) (6)
Anti‐PL‐12 antibody‐positive antisynthetase syndrome with recurrent digital ulcers (2018) (5)
Correction: Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis (2013) (5)
Significant association between CYP3A5 polymorphism and blood concentration of tacrolimus in patients with connective tissue diseases (2013) (5)
The International Consensus on ANA Patterns (ICAP) in 2021-The 6th Workshop and Current Perspectives. (2022) (5)
Autoantibodies to killer cell immunoglobulin‐like receptor 3DL1 in patients with systemic lupus erythematosus (2018) (5)
Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders (2018) (5)
AB0495 Post-marketing surveillance of tofacitinib in japanese patients with rheumatoid arthritis: an interim report of safety data (2018) (5)
Severe erosive arthropathy requiring surgical treatments in systemic lupus erythematosus (2009) (5)
Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthritis (2017) (5)
Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists (2018) (5)
Polymyositis associated with interstitial pulmonary fibrosis and glomerulonephritis. A report of two autopsy cases. (1981) (5)
Plasma sLOX-1 is a potent biomarker of clinical remission and disease activity in patients with seropositive RA (2016) (5)
Domain reactivity of autoantibodies to calpastatin in patients with systemic rheumatic diseases (2000) (5)
Predictive factors for structural remission using abatacept: Results from the ABROAD study (2018) (5)
Lifestyle and other related factors for the development of mixed connective tissue disease among Japanese females in comparison with systemic lupus erythematosus (2014) (5)
[Three cases with systemic rheumatic diseases who developed pulmonary lesions suggestive of bronchiolitis obliterans organizing pneumonia]. (1995) (5)
Developing an Electronic Health Record for Intractable Diseases in Japan (2011) (5)
Anti-transfer RNA antibodies in two patients with pulmonary fibrosis, Raynaud's phenomenon and polyarthritis (2005) (5)
Nucleotide sequence and genomic structure analyses of the p70 subunit of the human Ku autoantigen: evidence for a family of genes encoding Ku (p70)-related polypeptides (1992) (5)
Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL‐2Rγ−/− mice (2014) (5)
[A case of systemic lupus erythematosus associated with spinal epidural hematoma]. (1998) (4)
The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study (2019) (4)
Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. (2016) (4)
Personal Authentication Analysis Using Finger-Vein Patterns in Patients with Connective Tissue Diseases—Possible Association with Vascular Disease and Seasonal Change - (2015) (4)
[Two cases of interstitial pneumonia with anti-PL-12 (alanyl tRNA synthetase) antibodies]. (1996) (4)
Successful treatment with cyclosporin A of pure red cell aplasia associated with rheumatoid arthritis. (1996) (4)
[Frequency of anti-centromere antibodies in the anti-mitochondrial antibody positive sera]. (1989) (4)
Genetic landscape of interactive effects of HLA-DRB1 alleles on susceptibility to ACPA(+) rheumatoid arthritis and ACPA levels in Japanese population (2017) (3)
Feasibility of patient-oriented ultrasound joint selection: Cross-sectional observational study on rheumatoid arthritis (2019) (3)
IgG4-related disease – A new disease entity developed in the twenty-first century (2019) (3)
[Two cases of polymyositis associated with interstitial pneumonia with anti-OJ (isoleucyl tRNA synthetase) antibodies]. (1998) (3)
FRI0208 The possibility and predictive factors of maintaining low disease activity and joint structure after discontinuation of infliximab in ra patients: results from 3-year experience of rrr study (2013) (3)
Reliability and clinical utility of Enzyme-linked immunosorbent assay for detection of anti-aminoacyl-tRNA synthetase antibody. (2016) (3)
NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA (2012) (3)
Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study) (2016) (3)
The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method (2020) (3)
Only rheumatoid factor‐positive subset of anti‐citrullinated peptide/protein antibody‐negative rheumatoid arthritis may seroconvert to anti‐citrullinated peptide/protein antibody‐positive (2013) (3)
Anti-Na antibody: The study of a new autoantibody which reacts with a cell cycle dependent nuclear antigen. (1991) (3)
Accelerated Progression of Hepatocellular Carcinoma during Immunosuppressive Therapy with Abatacept for Rheumatoid Arthritis (2018) (3)
Two patients in the same family with anti-ARS antibody-associated myositis (2014) (3)
Successful treatment of primary Sjögren's syndrome with chronic natural killer lymphocytosis by high-dose prednisolone and indomethacin farnesil. (2007) (3)
Evaluation of risk factors for atherosclerosis using carotid ultrasonography in Japanese patients with rheumatoid arthritis (2019) (3)
Systemic sclerosis complicated by procainamide-induced lupus and antiphospholipid syndrome. (1998) (3)
Large cystic lesions of the upper lobes of the lungs in two patients with CHEST syndrome. (1984) (3)
Prevalence Of Autoantibodies To Aminoacyl-transferRNA Synthetases (ARS) Among Patients Who Were Diagnosed With Idiopathic Interstitial Pneumonias (IIPs) (2010) (3)
[Detection of autoantibodies in sera from patients with rheumatoid arthritis]. (1994) (3)
Correlation in the Coronal Angle between Knee and Hindfoot Was Observed in Patients with Rheumatoid Arthritis Unless Talocrural Joint Was Destroyed (2017) (3)
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. The Pathophysiology in Rheumatoid Arthritis.] (2018) (3)
Increased Ratio of CD14++CD80+ Cells/CD14++CD163+ Cells in the Infrapatellar Fat Pad of End-Stage Arthropathy Patients (2021) (2)
[Clinical significance of anti-Ku antibodies]. (1990) (2)
Long QT syndrome caused by adrenal insufficiency secondary to IgG4-related hypophysitis: a case report and review of the literature (2019) (2)
Enzyme-linked immunosorbent assay of anti-Ku antibodies using purified recombinant Ku antigens (1992) (2)
AB0636 Ustekinumab as a Therapeutic Option for Takayasu Arteritis –from Genetic Findings to Clinical Application- (2015) (2)
Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study (2022) (2)
Disseminated Mycobacterium mantenii infection with multiple purulent cutaneous lesions. (2015) (2)
Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis (2020) (2)
[Antigenic epitopes recognized by autoantibodies to calpastatin in patients with rheumatoid arthritis and their clinical significance]. (1997) (2)
A case of systemic lupus erythematosus complicated by subclinical Cushing’s syndrome: case report (2020) (2)
Amyopathic dermatomyositis complicated with eosinophilic pneumonia. (2014) (2)
High-Resolution Computed Tomography (HRCT) Features Of Interstitial Lung Disease In Dermatomyositis With Anti-CADM-140 Antibody (2011) (2)
Associated with Interstitial Lung Disease Asparaginyl-Transfer RNA Synthetase Anti-KS : Identification of Autoantibodies to and (1999) (2)
A novel apoptosis-inducing monoclonal antibody (anti-LHK) against a cell surface antigen on colon cancer cells (2005) (2)
Significant joint-destructive association of HLA-DRB1*04:05 independent of DAS28 in rheumatoid arthritis (2018) (2)
[Novel autoantibodies and their target antigens in rheumatoid arthritis]. (2002) (2)
[Hematologic, biochemical, and immunological tests in clinical practice of rheumatoid arthritis]. (2013) (2)
Human T cells expressing BEND3 on their surface represent a novel subpopulation that preferentially produces IL-6 and IL-8 (2014) (2)
[Role of Th17 cells and innate immunnity for the induction of autoimmune arthritis]. (2012) (2)
Anti–Double‐Stranded DNA Antibodies Recognize DNA Presented on HLA Class II Molecules of Systemic Lupus Erythematosus Risk Alleles (2021) (2)
Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL12 autoantibody: Signs of antisynthetase syndrome (2014) (2)
SAT0101 Abatacept Treatment Suppresses T Cell Activation in Anti-Cyclic Citrullinated Peptide Antibody (ACPA) Positive RA Patients but not in Acpa Negative RA Patients (2013) (2)
[Detection of isotype-specific autoantibodies to calpastatin in sera from patients with rheumatic diseases using heat-treated HeLa cell extract as an antigen source for immunoblotting]. (1998) (2)
Clinical significance of anti-nucleolar antibodies identified by immunoprecipitation assays in sera from patients with systemic sclerosis (1993) (2)
TAFRO syndrome complicated with occlusion of multiple cerebral arteries (2018) (2)
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis (2021) (2)
Association of anti-NR2 and U1RNP antibodies with neurotoxic inflammatory mediators in cerebrospinal fluid from patients with neuropsychiatric systemic lupus erythematosus (2020) (2)
Characterization of anticytoplasmic antibodies in patients with systemic autoimmune diseases (2003) (2)
ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis (2022) (2)
SAT0223 The Onsets of Myositis with Myositis-Specific Autoantibodies (MSAS) are Associated With The Seasons. (2013) (2)
[Case of MPO-ANCA positive interstitial pneumonitis and necrotizing, crescentic glomerulonephritis]. (1996) (2)
3. Autoantibodies in Rheumatoid Arthritis (2012) (2)
[Anti-Scl-70 antibody (anti-topoisomerase I antibody)]. (1999) (2)
A case of polyarteritis nodosa who developed severe pneumonia. (1998) (2)
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis]. (2009) (2)
[Analysis of autoantigens and clinical significance of antinuclear antibodies]. (1998) (2)
[Mechanisms of production and pathogenesis of autoantibodies]. (2007) (1)
OP0205 Efficacy and safety evaluation of iguratimod, a novel anti-rheumatic agent – a double-blind, comparative study of iguratimod-MTX combination in rheumatoid arthritis patients with an inadequate response to MTX (2013) (1)
A case of Behçet’s disease developing after poststreptococcal acute glomerulonephritis (2012) (1)
[Successful treatment of toe gangrene with moderate-dose steroid therapy in a patient with systemic sclerosis (CREST syndrome)]. (1997) (1)
Severe hypertension associated with multiple intrarenal microaneurysms in a patient with systemic lupus erythematosus and antiphospholipid antibodies (2002) (1)
[Progress in study of autoantibodies in connective tissue diseases]. (2002) (1)
A concomitant case of pathologically proven IgG4-related disease and ANCA-associated vasculitis: case report (2018) (1)
Evaluation for the clinical significance of cancer-association in anti-SRP antibody-positive myopathy (2017) (1)
[A case of anti-PL-7 antibody positive polymyositis with thrombotic microangiopathy]. (2017) (1)
Alanine transaminase is predominantly increased in the active phase of anti-HMGCR myopathy (2021) (1)
Increased number of T cells and exacerbated inflammatory pathophysiology in a human IgG4 knock-in MRL/lpr mouse model (2023) (1)
[Interferon-gamma in pathogenesis of rheumatoid arthritis]. (2005) (1)
Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort. (2021) (1)
[Clinical significance of anti-nucleolar antibodies detected by immunoprecipitation method in patients with systemic sclerosis]. (1992) (1)
Association of HumanLeukocyte Antigen Class II Genes with Autoantibody Profiles , but not with Disease Susceptibility in Japanese Patients with Systemic Sclerosis (2007) (1)
FRI0288 Immunogenicity is Associated with Lupus-Like Autoimmunity in Rheumatoid Arthritis Patients Treated with Infliximab (2014) (1)
AB0435 Effects of Prior Use of BIOLOGICS on the Safety and Effectiveness of Abatacept Administered with or without Methotrexate in Japanese Patients with Rheumatoid Arthritis: Sub-Analysis of the Abatacept All-Cases Post-Marketing Surveillance (2014) (1)
[Discussion meeting on treatment of rheumatoid arthritis with biologics and their side effects]. (2011) (1)
ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis (2022) (1)
Molecular Cloning of a cDNA for the B Polypeptide of the U snRNPs (1989) (1)
[Transfer RNA-associated anti-Wa antibody in patients with scleroderma and the target antigen NEFA/Nucleobindin-2]. (2007) (1)
OP0238 Fcgr2b and Multiple Hla Loci Are Associated with Susceptibility To IGG4-Related Disease (2016) (1)
A case of pulmonary arterial hypertension complicated by anti-neutrophil cytoplasmic antibody-associated vasculitis and systemic sclerosis (2021) (1)
[Immunomodulation and immunomodulators]. (1981) (1)
[Two cases of rheumatoid arthritis presenting autoimmune hepatic diseases]. (1994) (1)
A case of anti-aminoacyl tRNA synthetase antibody syndrome complicated by hemophagocytic syndrome. (2016) (1)
FRI0122 Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera from patients with rheumatoid arthritis (2017) (1)
Simultaneous development of cutaneous vasculitis and an autoimmune bullous skin disease during anti-TNF therapy for rheumatoid arthritis: a case report and review of the literature (2018) (1)
[Autoantibodies in connective tissue diseases]. (2005) (1)
[A new autoantibody anti-Na which reacts with a cell cycle-dependent nuclear antigen]. (1994) (1)
Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases (2021) (1)
Recent advances on the genetics of rheumatoid arthritis: current topics and the future (2012) (1)
Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study (2020) (1)
[Anti-Jo-1 autoantibodies (anti-histidyl tRNA synthetase autoantibodies)]. (1999) (1)
Clinical Images: Chronic Nonbacterial Osteomyelitis (2017) (1)
A main contribution of DRB 1 * 04 : 05 among shared epitope and involvement of 57 th DRB 1 amino acid in association with joint destruction in ACPA ( + ) (2015) (1)
Long-term follow-up of patients with anti-cyclic citrullinated peptide antibody-positive connective tissue disease: a retrospective observational study including information on the HLA-DRB1 allele and citrullination dependency (2020) (1)
Successful Treatment of Polymyositis by Immunoadsorption in a Patient with Polymyositis-Systemic Sclerosis Overlap(Collagen Disease,General Presentation,Proceedings of the Thirteenth Annual Meeting of Japanese Society for Apheresis) (1994) (1)
Oral steroid decreases the progression of joint destruction of large joints in the lower extremities in rheumatoid arthritis (2019) (1)
AB0472 Predicting Factors Associated with Sustained Clinical Remission by Abatacept are Different Between in Younger and Elderly Patients with Biologic-Naïve Rheumatoid Arthritis (Abroad Study) (2015) (1)
Title Comprehensive microRNA Analysis Identifies miR-24 andmiR-125 a-5 p as Plasma Biomarkers for Rheumatoid Arthritis (2018) (1)
[Rheumatoid arthritis: progress in diagnosis and treatment. Topics: II. Pathophysiology; 3. Autoantibodies in rheumatoid arthritis]. (2012) (1)
Multiple digital ulcers on the hands and feet in anti‐PL‐12 antibody‐positive anti‐synthetase syndrome without Raynaud’s phenomenon (2021) (1)
Prospective study of a systemic sclerosis/dermatomyositis overlap patient presenting with anti-Ku and anti-Ki antibodies (2002) (1)
Isolation of vascular smooth muscle antigen-reactive CD4(+)αβTh1 clones that induce pulmonary vasculitis in MRL/Mp-Fas(+/+) mice. (2016) (1)
SAT0069 A Clinical, Pathological and Genetic Characterization of Methotrexate-Associated Lymphoproliferative Disorders (2013) (1)
Abatacept Ameliorates Both Glandular and Extraglandular Involvements in Patients With Sjögren's Syndrome Associated with Rheumatoid Arthritis: Findings from an Open-Label, Multicenter, 1-Year, Prospective Study: the ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren's Syndrome Endocrinopat (2022) (1)
AB1335 Serum mmp-3 is closely related to knee joint symptoms in rheumatoid arthritis patients: a cross-sectional study from kurama cohort (2018) (1)
Title Serum BAFF and APRIL levels in patients with IgG 4-relateddisease and their clinical significance (2019) (0)
A male with rheumatoid arthritis and lung cancer. (1994) (0)
A case of mixed connective tissue disease/Sjoegren's syndrome associated with primary biliary cirrhosis. (1994) (0)
FRI0673 Clinical remission in tocilizumab-using rheumatoid arthritis patients can be overestimated: a cross sectional study using ultrasound sonography (2017) (0)
Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: Results of the HAWK postmarketing surveillance study in Japan (2020) (0)
[Refractory nature of collagen diseases: discussion]. (2001) (0)
[Novel autoantibodies that recognize native transfer RNAs in patients with systemic rheumatic diseases]. (1997) (0)
Title Periodontitis and Porphyromonas gingivalis in PreclinicalStage of Arthritis Patients (2019) (0)
GM-CSF as a therapeutic target in autoimmune diseases (2016) (0)
[Efficacy of disease modifying anti-rheumatic drugs on bone destruction in rheumatoid arthritis]. (2015) (0)
Mixed connective tissue disease. Progress of diagnosis and treatment. Disease state and diagnosis. 1.Etiology and mechanism of pathogenesis. (1996) (0)
[Proper usage of clinical tests in diagnosis and therapy of collagen diseases]. (2003) (0)
Arthralgia (itis) : Advance on diagnosis and treatment.9.Diagnosis and treatment for hypertrophic osteoarthropathy. (1994) (0)
AB1223 Ultrasonography examination of elbows is useful when combined with examination of pip and wrist joints (2018) (0)
Publishing Immunological Medicine-changing from Japanese Journal of Clinical Immunology (2018) (0)
AB0274 The Influence of Continuous Remission Rate on Functional Disability and Radiographic Progression for Rheumatoid Arthritis in A Japanese Observational Cohort (2014) (0)
[The cutting-edge of medicine: progress of autoantibodies in polymyositis and dermatomyositis-biomarker for myositis-associated interstitial lung disease]. (2012) (0)
[Polymyositis and dermatomyositis]. (2000) (0)
Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis. (2022) (0)
FRI0098 A Certain Portion of Active Established Rheumatoid Arthritis Patients with Significant Joint Destruction Are Misclassified as Being in Boolean Remission: A Cross-Sectional Study Using Ultrasound Sonography (2016) (0)
Correction to: Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study (2021) (0)
[Clinical significance of anti-histone antibody assay]. (1990) (0)
[Small nuclear U-RNP antibodies]. (1988) (0)
[Autoimmune diseases and RNA]. (2009) (0)
AB0513 Treatment Strategy Targeting Structural Remission in Patients with Early Rheumatoid Arthritis: A Multi-Central, Prospective, Comparative Study Targeting Joint Damage to Zero (Zero-J Study) (2015) (0)
Autoantibodies in Rheumatoid Arthritis (2006) (0)
Development of new therapies for intractable conditions in systemic autoimmune diseases (2008) (0)
Immunogenetic features associated with myositis in Japanese patients with anti-Ku autoantibodies (1998) (0)
[Study on combined of auranofin, salazosulfapyridine and methotrexate in rheumatoid arthritis]. (1994) (0)
Instructions for use Title Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients withrheumatoid arthritis (2017) (0)
Modern Rheumatology indexed in MEDLINE (2006) (0)
Incidence of Ocular Complications in Systemic Lupus Erythematosus (1999) (0)
Characterization and evolutionary aspect of a Trimeresurus flavoviridis serum inhibitor, PLI-I, against its venom basic phospholipase A2 isozymes (1999) (0)
A case of late-onset polymyositis with autoantibodies to the signal recognition particle (1998) (0)
[Anti-Ku antibodies]. (1999) (0)
[Progress in clinical tests and the pathophysiological study of collagen diseases--anti-ribonucleoprotein antibodies]. (1998) (0)
[Structure and function of nuclear and cytoplasmic protein antigens recognized by autoantibodies]. (1992) (0)
The cut-off levels of serum creatine kinase as a diagnostic marker for myopathy with anti-hmg-cr or anti-srp autoantibodies positive (2017) (0)
Fatostatin ameliorates inflammation without affecting cell viability (2022) (0)
OP0114 Ana development is associated with poor response to biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis (2018) (0)
Clinical Significances of Rare Autoantibodies to Small Nuclear and Cytoplasmic Ribonucleoproteins (1989) (0)
14-2 Inverse association between air pressure and rheumatoid arthritis synovitis (2014) (0)
FRI0352 Efficacy of biologics in patients with refractory takayasu arteritis and analysis of their genetic backgrounds (2017) (0)
SAT0121 Changes in Cytokine Profiles in Rheumatoid Arthritis Patients During Abatacept Treatment (2013) (0)
THU0065 Clinical significance of anti-asparaginyl trna synthetase autoantibodies (2001) (0)
Diagnosis and Treatment of Diffuse Connective Tissue Diseases (2020) (0)
OP0036 Molecular cloning and characterisation of autoantigen recognised by anti-wa antibodies in patients with systemic sclerosis (2001) (0)
FRI0621 ASSOCIATIONS BETWEEN ORGAN INVOLVEMENTS AND GENDER, ALLERGY, AND MALIGNANCY IN 166 PATIENTS WITH IGG4-RELATED DISEASE (2019) (0)
Novel development of collagen disease rheumatism medical care. II. Treatment. 1. Guideline of the articular rheumatism treatment. (2005) (0)
[Immunodeficiency in autoimmune diseases]. (2000) (0)
[Diagnosis and therapy of hypertrophic osteoarthropathy]. (1994) (0)
[Progress in detection of autoantibodies and analysis of autoantigens]. (2005) (0)
[Progress in detection of autoantibodies and analysis of autoantigens]. (1999) (0)
Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study (2018) (0)
366 Splicing factor proline/glutamine-rich (sfpq) is a novel autoantigen of anti-mda5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis (2017) (0)
Further Characterization of the Anti-Wa Antibody to a tRNA-Related Protein in Progressive Systemic Sclerosis (1989) (0)
SAT0239 T Cell CD80/Cd86 Co-Stimulatory Blockade Effectively Suppresses CD25 (+) in CD4 (+) T Cell Subpopulation but not the ACPA Titers in the Course of 48-Week Treatment of Patients with Rheumatoid Arthritis (2014) (0)
[Anti-U3RNP (fibrillarin) and anti-7-2RNP (Th/To) antibodies]. (1999) (0)
AB0230 Centromere Pattern Exhibits A Specific Distribution of Titers among Anti-Nuclear Antibodies (ANAS) and Characterizes A Distinct Subset in Rheumatoid Arthritis (2016) (0)
[Progress in the study of allergy and collagen disease in the last 100 years: Mixed connective tissue disease]. (2002) (0)
[Anti-histone antibodies]. (1999) (0)
Time-averaged disease activity fits better joint destruction in rheumatoid arthritis (2017) (0)
MHC polymorphism and diseases (WS-088) Chairpersons: Yasuharu Nishimura, Narinder Mehra (2010) (0)
THU0305 A Nationwide Study of Systemic Lupus Erythematosus in Japanese Identified Subgroups of Patients with Clear Signs/Clinical Marker Patterns and Found that Particular Signs/Clinical Markers are Associated with Age and/or Sex (2013) (0)
7. Treatment of Collagen Diseases - Use of Immunosuppressive Drugs (2008) (0)
FRI0115 The Influence of Handedness To The Laterality of Clinical and Radiological Articular Involvement in Rheumatoid Arthritis (2016) (0)
SAT0150 Prevalence of Forefoot Deformities in Patients with Rheumatoid Arthritis – A Cross-Sectional Study from Kurama Cohort- (2014) (0)
Vaccination with autoreactive CD4Th1 clones in lupus-prone MRL/Mp-Fas mice (2017) (0)
SAT0211 Effectiveness and Safety of Tocilizumab in Biologics Naïve RA Patients – PMS for Investigating Success in Achieving Clinical and Functional Remission and Sustaining Efficacy with Tocilizumab in Biologics-Naïve RA Patients (First Bio) Study (2015) (0)
[Meningitis in mixed connective tissue disease]. (2000) (0)
AB0439 T Cell CD80/Cd86 Co-Stimulatory Blockade Does not Suppress CD8 (+) Subpopulation in the Course of 48-Week Treatment of Patients with Rheumatoid Arthritis (2014) (0)
[Progress in detection of autoantibodies and analysis of autoantigens]. (2010) (0)
THU0165 Obesity as one of the commodities was the robustest prediction factors for post therapeutic clinical remission of rheumatoid arthritis with short disease duration – results from kansai consortium for well-being of rheumatic disease patients (2018) (0)
27 The international consensus on standardized nomenclature of antinuclear antibody hep-2 cell patterns (icap) initiative – its impact and update from 3rd icap (2017) (0)
Regulatory T cells and autoimmunity (PP-073) (2010) (0)
5. Recent Progress of Diagnosis and Treatment in Connective Tissue Diseases (2018) (0)
Molecular characterization of the ku autoantigen (1988) (0)
[Anti-PL-7 autoantibodies and anti-PL-12 autoantibodies (anti-aminoacyl-tRNA 'other than histidyl' synthetase autoantibodies)]. (1999) (0)
[Anti-inflammatory agents and corticosteroids for treatment of rheumatoid arthritis]. (2008) (0)
AB0268 Metatarsophalangeal Joint Dislocation has Clinical Impact on Global Functional Impairment in Patients with Rheumatoid Arthritis – a Cross-Sectional Study from Kurama Cohort- (2015) (0)
SAT0594 Will Anti-Cyclic Citrullinated Peptide Antibody-Positive Connective Tissue Disease Patients Develop Rheumatoid Arthritis? Association with HLA-DRB1 Shared Epitope (2015) (0)
Correction to: The International Consensus on ANA Patterns (ICAP) in 2021-the 6th Workshop and Current Perspectives. (2022) (0)
[Pathological features of myositis with myositis -specific autoantibodies]. (2014) (0)
Title Serological and progression differences of joint destruction in the wrist and the feet in rheumatoid arthritis-A cross-sectional cohort study (2018) (0)
WS3_1 The Synergistic Effects of HLA-B*52 and Risk Allele at a SNP in IL12B Region on Complication of Aortic Regurgitation in Patients with Takayasu Arteritis (2017) (0)
AB1133 High consumption of seafoods or vegetables negatively correlates with disease activity of rheumatoid arthritis (2017) (0)
A Novel Sphingomyelin Synthase Gene, SMS1-Regulated Sphingomyelin/Ceramide-Rich Microdomain Plays a Crucial Role in Fas-Mediated Apoptosis. (2004) (0)
[Mixed connective tissue disease: progress in diagnosis and treatment. II. Physiopathology and diagnosis. 1. Etiology and pathogenesis]. (1996) (0)
Genetic architecture underlying IgG-RF production is distinct from that of IgM-RF. (2022) (0)
THU0063 Autoantibodies to human myc far upstream element-binding protein in patients with rheumatoid arthritis (2001) (0)
SAT0615 THE DIFFERENT EFFECTS OF CIGARETTE SMOKING ON ANTI-CITRULLINATED CYCLIC PROTEIN ANTIBODY AND RHEUMATOID FACTOR FORMATION IN RELATION TO SHARED EPITOPE ALLELES IN JAPANESE RA PATIENTS (2019) (0)
[Treatment of collagen diseases. Clinical application of immunosuppressive agents]. (2008) (0)
[Mixed connective tissue disease: progress in diagnosis and treatment. III. Treatment. 3. Clinical aspects of specific conditions and treatment. 3) Interstitial pulmonary lesions and serositis]. (1996) (0)
B cell development (PP-030) (2010) (0)
FRI0349 The SNP RS6871626 located in IL12B region may influence on vascular lesions of takayasu arteritis (2017) (0)
FRI0573 Integration of Time-Averaged DAS28 Fits Better Joint Destruction In Rheumatoid Arthritis Than One-Time DAS28 and Identifies A Significant Joint-Destructive Association of HLA-DRB1*04:05 Which is Independent of ACPA and DAS28 (2016) (0)
A 35-year-old woman with mixed connective tissue disease who developed progressive dyspnea. (1994) (0)
SAT0002 ACPA-negative rheumatoid arthritis consists of two genetically distinct subsets based on RF positivity (2013) (0)
2. Anti-CCP Antibody (2007) (0)
[111th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Immunity and diseases in internal medicine--Frontier of pathophysiology and treatment; Introduction]. (2014) (0)
THU0006 Trans-ethnic meta-analysis of genome-wide association studies identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis (2017) (0)
[B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis]. (2007) (0)
INFLAMMATORY MYOPATHIES P.153Tight association between microinfarction and capillary MAC deposition in dermatomyositis (2018) (0)
26 Clinical significance of autoantibodies in myositis with interstitial lung disease (2017) (0)
SLE and other connective tissue diseases (human studies) (PP-016) (2010) (0)
Evaluation of the efficacy and safety of the combined therapy with diclofenac sodium slow release capsule and suppository in the treatment of rheumatoid arthritis. Including the assessment of quality of life measures. (1995) (0)
AB0486 Effect of Baseline Disease Duration on Development of Clinical Remission in the RA Patients Receiving Tocilizumab – Data from PMS with Tocilizumab in Biologics-Naïve RA Patients (First Bio) Study (2015) (0)
AB0294 Analysis of Prognosis Factors for Functional Disability in a Japanese Cohort for Rheumatoid Arthritis (2015) (0)
Th17 (WS-014) Chairpersons: Akihiko Yoshimura, Joseph E. Craft (2010) (0)
Autoimmune autonomic neuropathy with Sjogren syndrome: Significance of anti ganglionic acetylcholine receptor antibody (2007) (0)
fluid of patients with neuropsychiatric systemic lupus erythematosus Association between anti-U 1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal (2014) (0)
Clinical, serological, and pathological features of inflammatory myopathies with systemic sclerosis (2017) (0)
FRI0210 Real-world hawk study: long-term safety and effectiveness of adalimumab with higher-dose methotrexate in japanese patients with early rheumatoid arthritis (2017) (0)
THU0057 Lipid profiling of plasma in rheumatoid arthritis patients by liquid chromatography–tandem mass spectrometry (2017) (0)
Sensorimotor polyneuropathy as an initial clinical manifestation of sarcoidosis (2005) (0)
[Non-histone proteins as autoantibody-reactive antigens]. (1988) (0)
Analysis of extractable nuclear antigens by blotting technique (1988) (0)
SAT0301 Periarticular Osteoporosis of the Forearm Correlated with Joint Destruction and Functional Impairment in Patients With Rheumatoid Arthritis (2015) (0)
[Susceptibility HLA alleles and amino acids to Takayasu arteritis]. (2014) (0)
THU0462 Anti-Citrullinated Peptide/Protein Antibody (ACPA)-Negative RA Shares Large Proportion of Susceptibility Genes with Acpa-Positive RA (2014) (0)
Immunospecificity and Clinical Association of Autoantibodies in Sera Precipitating U 1 and U 2 Small Nuclear RNAs (1989) (0)
THU0194 Association between autoantibodies and soluble factors in cerebrospinal fluids from patients with neuropsychiatric systemic lupus erythematosus (2013) (0)
[Anti-U3RNP(fibrillarin) and anti-7-2RNP(Th/To) antibodies]. (2010) (0)
FRI0143 Type I Interferon Plays A Key Role in Immunogenicity and Lupus-Like Autoimmunity in Patients with Rheumatoid Arthritis Treated by Infliximab (2015) (0)
THU0067 Analysis of autoantigens recognised by autoantibodies that immunoprecipitate high molecular weight nucleic acids (2001) (0)
[Clinical significance of anti-CCP antibody in diagnosis of collagen diseases]. (2007) (0)
Rheumatoid Arthritis May Predict Articular Destruction 2 Years Later Clinical Activity After 12 Weeks of Treatment with Nonbiologics in Early (2010) (0)
Similarity and difference between systemic lupus erythematosus and NZB/W F1 mice by multi-omics analysis. (2023) (0)
FRI0331 Trough concentration of mycophenolic acid correlates with renal function and serum albumin level in japanese patients with sle (2018) (0)
Advances of clinical laboratory for collagen disease. II. Advances of collagen disease test and disease state elucidation. 5. Anti-ribonucleoprotein antibody. (1998) (0)
Title Screening for IgG 4-type anti-nuclear antibodies in IgG 4-relateddisease (2018) (0)
Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis (2017) (0)
OP0056 Association of IL-12P40 and IL-12P70 with Pathophysiology of Takayasu Arteritis (2016) (0)
FRI0206 Abatacept (CTLA4-IG) suppresses T cell activation and reduces TH17 cells as well as plasma IL-6 in patients with rheumatoid arthritis (2013) (0)
WS / PP-088-04 A greater influence of HLA-B than MICA on the occurrence of celiac disease in DQ 2 patients with type 1 diabetes (2010) (0)
A new autoantibody to valyl transfer RNA synthetase associated with anti-synthetase syndrome. (2022) (0)
SAT0422 Indirect pathogenic roles of cerebrospinal fluid anti-u1rnp antibodies in the presence of anti-nr2 antibodies in patients with neuropsychiatric systemic lupus erythematosus (2018) (0)
2. Guideline for Drug Treatment for Rheumatoid Arthritis and Its Validation (2009) (0)
[Disease modifying anti-rheumatic drugs (DMARDs): an overview]. (2005) (0)
P-569 Efficacy and survival benefit of prophylactic Shakuyaku-Kanzou-Tofor myalgia/arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer (2005) (0)
AB1094 Leucine-Rich-Alpha Glycoprotein-1 (LRG1) and Lupus Nephritis (2015) (0)
THU0384 Juxtaarticular Osteoporosis Exists in the Wrist Joint from the Early Stage of Rheumatoid Arthritis (2013) (0)
Rheumatoid Factor Is Associated with the Distribution of Hand Joint Destruction in a Dose-Dependent Manner (2015) (0)
Title Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis : a retrospective clinical study (2019) (0)
AB0506 Longitudinal change of the titer of anti-mda5 antibody and association with prognosis in dermatomyositis with interstitial pneumonia (2013) (0)
Molecular Cloning of the Human Autoantigen KU (p70/p80), a DNA-Terminal-Binding Protein Complex (1989) (0)
3. Anti-inflammatory Agents and Corticosteroids for Treatment of Rheumatoid Arthritis (2008) (0)
Fas MRL/Mp-Lupus Erythematosus Lesions in Deficient Leptin Signaling Ameliorates (2014) (0)
Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome (DNA-binding protein/molecular cloning/autoimmune disease/"leucine zipper") (2016) (0)
[Immunologic tests: Anti-U3RNP (fibrillarin) and anti-7-2RNP (Th/To) antibodies]. (2005) (0)
International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results (2016) (0)
Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor 1 Predicts the Changes of Rheumatoid Factor Titers in Rheumatoid Arthritis (2019) (0)
Interstitial lung disease in myositis : clinical subsets , biomarkers , and treatment . Author ( s ) (2017) (0)
THU0015 VARIATION IN MACROPHAGES DIFFERENTIATION AND SREBF1 EXPRESSION BETWEEN INFRAPATELLAR FAT PAD AND SUBCUTANEOUS TISSUES FROM RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS (2019) (0)
[Collagen diseases and autoantibodies--current topics]. (2004) (0)
SAT0095 Leucine-Rich Alpha2-Glycoprotein Is A Useful Biomarker To Evaluate The Clinical Disease Activities of Rheumatoid Arthritis under Treatments (2016) (0)
FRI0511 Detection of Anti-Th/To Antibodies in Patients with Various Rheumatic Diseases and their Clinical Features (2014) (0)
AB0950 Leucine-Rich Alpha-2 Glycoprotein (LRG) as A Possible Urinary Marker for Lupus Nephritis (2016) (0)
Rosai-Dorfman disease with aortic involvement in a 58-year-old man: a case report (2019) (0)
FRI0083 Predictors for the discrepancy between patient’s and evaluator’s global assessment in rheumatoid arthritis: kurama cohort study (2013) (0)
[Systemic lupus erythematosus]. (2021) (0)
[Immunologic tests: Anti citrullinated protein (filaggrin/CCP) antibodies]. (2005) (0)
Prognostic Values Of Radiological Patterns And Disease Extent On High-Resolution Computed Tomography In Myositis-Associated Interstitial Lung Disease (2012) (0)
AB1013 Prediction of bone mineral density changes in patients with rheumatoid arthritis (2018) (0)
autoimmune disease Detection of T cell responses to a ubiquitous cellular protein in (2014) (0)
Title Immunogenicity and lupus-like autoantibody production can be linked to each other along with type i interferon production in patients with rheumatoid arthritis treated with infliximab : A retrospective study of a single center cohort (2019) (0)
Chromosomal localization of the mouse DNA double-strand break repair gene Ku p70 and Ku p80/XRCC5. (1996) (0)
SAT0200 Clinical Application of the Soluble Lectin-Like Oxidized LDL Receptor-1 (SLOX-1) in Rheumatoid Arthritis: from Bench to Bedside (2014) (0)
[Autoantibodies and analysis of target antigens]. (1999) (0)
THU0023 DETAILED PROFILE OF CO-OCCURRENCE OF RELAPSING POLYCHONDRITIS AND AUTOIMMUNE THYROID DISEASE (2020) (0)
AB0781 Clinical periodontal disease predicts the future development of chronic inflammatory arthritis. (2013) (0)
[Guidelines for drug therapy of rheumatoid arthritis]. (2005) (0)
Exchange of information in rheumatology between east and west: from Man'yo-shu to the future. (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Tsuneyo Mimori?

Tsuneyo Mimori is affiliated with the following schools:

Tsuneyo Mimori's Academic­Influence.com Rankings

Tsuneyo Mimori's Degrees

Similar Degrees You Can Earn

Why Is Tsuneyo Mimori Influential?

Tsuneyo Mimori's Published Works

Published Works

What Schools Are Affiliated With Tsuneyo Mimori?

Tsuneyo Mimori's AcademicInfluence.com Rankings